Amplitude, Inc.
AMPL Nasdaq Services-Prepackaged Software Financials FY2019βFY2025
What Amplitude, Inc. does
No business description yet.
- Legal name
- Amplitude, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 19, 2026
- Accession Β· CIK
- 0001193125-26-057847
0001866692
Revenue and margins
Amplitude, Inc. had $343M of revenue in fiscal 2025, up 14.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $28.2M in fiscal 2025, 8.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Amplitude, Inc. returned $30.7M to shareholders in fiscal 2025, 109% of free cash flow. The diluted share count rose 6.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Amplitude, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $307M | $230M | $322M | $241M | $192M |
| Current ratio | 3.9x | 2.6x | 2.9x | 2.1x | 1.6x |
| Quick ratio | 3.9x | 2.6x | 2.9x | 2.1x | 1.6x |
| Total assets | $400M | $414M | $434M | $446M | $421M |
| Total liabilities | $93.8M | $119M | $139M | $149M | $175M |
| Shareholders' equity | $307M | $295M | $295M | $297M | $245M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 2 / 8 | 3 / 8 | 6 / 8 | 4 / 8 | 4 / 8 |
| Accruals ratio | β | β8.1% | β15.0% | β21.6% | β27.4% | β25.7% | β27.3% |
| Altman Z'' | β | β | β | β | β | β | β |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $68.4M | $102M | $167M | $238M | $276M | $299M | $343M |
| Gross profit | $46.3M | $72.0M | $115M | $168M | $204M | $222M | $254M |
| Research and development | $19.0M | $26.1M | $48.3M | $80.6M | $90.1M | $97.6M | $97.6M |
| Pretax income | β$32.9M | β$23.7M | β$74.0M | β$92.6M | β$89.1M | β$92.5M | β$85.3M |
| Income tax | $0.7M | $0.8M | $1.0M | $0.8M | $1.3M | $1.8M | $3.2M |
| Net income | β$33.5M | β$24.6M | β$75.0M | β$93.4M | β$90.4M | β$94.3M | β$88.5M |
| Diluted EPS | β$1.38 | β$0.98 | β$1.46 | β$0.84 | β$0.77 | β$0.76 | β$0.67 |
| Diluted shares | 0.02B | 0.03B | 0.05B | 0.11B | 0.12B | 0.12B | 0.13B |
| Cash flow | |||||||
| Cash from operations | β$16.0M | β$10.4M | β$31.7M | β$5.4M | $25.6M | $18.5M | $29.8M |
| Capital expenditure | $0.6M | $1.0M | $1.5M | $3.6M | $1.3M | $1.7M | $1.6M |
| Free cash flow | β$16.7M | β$11.4M | β$33.2M | β$9.0M | $24.4M | $16.8M | $28.2M |
| Depreciation and amortization | $0.7M | $1.7M | $3.1M | $4.7M | $5.6M | $6.1M | $9.6M |
| Stock-based compensation | $7.3M | $16.6M | $34.4M | $67.2M | $88.3M | $100M | $92.1M |
| Acquisitions | $0.0M | $3.7M | $1.7M | $0.4M | $0.0M | $16.1M | $3.0M |
| Share buybacks | β | β | β | β | $0.6M | $0.0M | $30.7M |
| Dividends and buybacks | β | β | β | β | $0.6M | $0.0M | $30.7M |
| Balance sheet | |||||||
| Cash and short-term investments | $79.8M | $118M | $307M | $230M | $322M | $241M | $192M |
| Current assets | β | $149M | $355M | $284M | $380M | $304M | $257M |
| Current liabilities | β | $53.3M | $90.6M | $109M | $132M | $145M | $165M |
| Property and equipment, net | β | $2.7M | $4.8M | $9.4M | $10.1M | $16.3M | $18.6M |
| Goodwill | β | $1.0M | $4.1M | $4.1M | $4.1M | $24.4M | $25.2M |
| Intangible assets | β | $2.0M | $3.6M | $2.0M | $0.6M | $4.4M | $6.4M |
| Total assets | β | $175M | $400M | $414M | $434M | $446M | $421M |
| Total liabilities | β | $54.4M | $93.8M | $119M | $139M | $149M | $175M |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | β$62.9M | β$67.1M | $307M | $295M | $295M | $297M | $245M |
| Margins | |||||||
| Gross margin | 67.7% | 70.3% | 69.1% | 70.4% | 74.0% | 74.3% | 74.0% |
| Net margin | β49.0% | β24.0% | β44.8% | β39.2% | β32.7% | β31.5% | β25.8% |
| FCF margin | β24.4% | β11.1% | β19.9% | β3.8% | 8.8% | 5.6% | 8.2% |
| Returns | |||||||
| Return on equity | β | β | β62.6% | β31.0% | β30.6% | β31.9% | β32.7% |
| Return on assets | β | β14.0% | β26.1% | β22.9% | β21.3% | β21.4% | β20.4% |
| Return on tangible equity | β | β | β25.1% | β32.3% | β31.2% | β35.2% | β41.4% |
| Growth | |||||||
| Revenue growth | β | 49.7% | 63.2% | 42.3% | 16.1% | 8.3% | 14.7% |
| FCF growth | β | β | β | β | β | β31.1% | 68.1% |
| Share count change | β | 3.0% | 104.9% | 117.0% | 4.9% | 6.0% | 6.5% |
| Financial health | |||||||
| Current ratio | β | 2.8x | 3.9x | 2.6x | 2.9x | 2.1x | 1.6x |
| Quick ratio | β | 2.8x | 3.9x | 2.6x | 2.9x | 2.1x | 1.6x |
| Capital allocation | |||||||
| Capex / revenue | 0.9% | 1.0% | 0.9% | 1.5% | 0.5% | 0.6% | 0.5% |
| Stock comp / revenue | 10.7% | 16.2% | 20.6% | 28.2% | 32.0% | 33.4% | 26.8% |
| Payouts / FCF | β | β | β | β | 2.7% | 0.0% | 109.0% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 2.0 | 3.0 | 6.0 | 4.0 | 4.0 |
| Accruals ratio | β | β8.1% | β15.0% | β21.6% | β27.4% | β25.7% | β27.3% |
Source: SEC EDGAR XBRL filings (CIK 0001866692). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.